Niki BioSolutions NIKI
NASDAQ NIKI
$4.60 -0.26 (-5.35%)
At close: Oct 2, 2026 · 4:00 PM EDT

Niki BioSolutions (NIKI) Long-Term Debt Issuances (2024 - 2025)

Updated

Niki BioSolutions (NIKI) reported Long-Term Debt Issuances of $250,000 for FY2025.

Analysis

Niki BioSolutions (NIKI) Long-Term Debt Issuances (2024 - 2025) Analysis & Trends

Dating back to FY2019, Niki BioSolutions' Long-Term Debt Issuances record includes 7 years.

  • Long-Term Debt Issuances has a five-year compound annual growth rate of -24.2% (FY2020 to FY2025).
  • Five-year annual Long-Term Debt Issuances spans a low of $200,000 in FY2024 and a high of $3.5 million in FY2021.
  • According to Business Quant data, Long-Term Debt Issuances came in at $200,000 in FY2024, $2.5 million in FY2023 (+400.0%), $500,000 in FY2022 (-85.7%) and $3.5 million in FY2021 (+250.0%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Niki BioSolutions 2.65 Mn 2.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2025 150,000.00
Nov 30, 2024 100,000.00
Aug 31, 2024 100,000.00
API Access

Niki BioSolutions Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=NIKI&period=max&api_key=YOUR_API_KEY